Nina McCarthy

Dr

  • The University of Western Australia (M504), 35 Stirling Highway,

    6009 Perth

    Australia

  • 99 Citations
  • 5 h-Index
20112019
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Genetic epidemioloy
  • Statistical genetics
  • Genetics of cardiovascular disease
  • Genetics of psychiatric disorders
  • Genetics of complex disease
  • Family-based genetic studies

Fingerprint Dive into the research topics where Nina McCarthy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles
Genome Medicine & Life Sciences
Schizophrenia Medicine & Life Sciences
Endophenotypes Medicine & Life Sciences
Personality Assessment Medicine & Life Sciences
Exome Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Methylenetetrahydrofolate Reductase (NADPH2) Medicine & Life Sciences
Genetic Research Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

INCREASED PREDICTED C4A EXPRESSION IS ASSOCIATED WITH COGNITIVE DEFICIT IN BOTH SCHIZOPHRENIA AND ALZHEIMER'S DISEASE

McCarthy, N., Laws, S. M., Porter, T., Burnham, S. C., Moses, E. K. & Jablensky, A., 2019, In : European Neuropsychopharmacology. 29, p. S871-S871 1 p.

Research output: Contribution to journalAbstract/Meeting Abstract

2 Citations (Scopus)

Rediscovering the value of families for psychiatric genetics research

Glahn, D. C., Nimgaonkar, V. L., Raventos, H., McCarthy, N., Jablensky, A., Curran, J. E., Almasy, L. & Blangero, J., Apr 2019, In : Molecular Psychiatry. 24, 4, p. 523-535

Research output: Contribution to journalReview article

Genetic Research
Psychiatry
Pedigree
Genome
Psychotic Affective Disorders
1 Citation (Scopus)
48 Downloads (Pure)
Open Access
File
Personality Assessment
Endophenotypes
Cognition
Schizophrenia
Personality

Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

McCarthy, N. S., Vangjeli, C., Surendran, P., Treumann, A., Rooney, C., Ho, E., Sever, P., Thom, S., Hughes, A. D., Munroe, P. B., Howard, P., Johnson, T., Caulfield, M., Shields, D. C., O'Brien, E., Fitzgerald, D. J. & Stanton, A. V., 1 Feb 2018, In : Atherosclerosis. 269, p. 42-49 8 p.

Research output: Contribution to journalArticle

Open Access
Thromboxane A2
Disease-Free Survival
Aspirin
Single Nucleotide Polymorphism
Alleles

Projects 2014 2019